COVID-19 vaccines pricing policy options for low-income and middle- income countries

BMJ Glob Health. 2021 Mar;6(3):e005347. doi: 10.1136/bmjgh-2021-005347.

Authors

Javier Guzman¹, Tamara Hafner², Lalla Arkia Maiga², Ursula Giedion³

Affiliations

¹ USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, Virginia, USA jguzman@mtapsprogram.org.
² USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, Virginia, USA.
³ Inter-American Development Bank, Washington, District of Columbia, USA.

No abstract available

Keywords: COVID-19; health policy; public health; vaccines.

Publication types

Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

COVID-19 Vaccines / economics*
COVID-19* / economics
COVID-19* / prevention & control
Developing Countries / economics*
Global Health / economics
Health Policy / economics*
Humans
Pandemics

Substances

COVID-19 Vaccines